8 enregistrements totalisant 2,657,653.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
| Instituts de recherche en santé du Canada | $2,657,653 | 8 enregistrements |
Characterization of a new group of vesicular transport diseases.
Role of fibronectin mutations in spondylometaphyseal dysplasia and idiopathic scoliosis.
The specific objectives of this funding opportunity are to: • Enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on co...
Genetic bone diseases; new genes and new treatments
Genetic bone diseases; new genes and new treatments
• CIHR-IG will provide funding for applications that are determined to be relevant to its mandate: o The Institute of Genetics (IG) supports research on the human and model genomes and on all aspect...
Phenylbutyrate use to target phosphorylation pathways in human disease
Maud Menten New Principal Investigator Prize 2014 - Clinical Theme. This prize represents the highest ranked CIHR Operating Grant application from the combined results of the September 2013 and March...